Garamycin gentamicin inj
Products billed under this code include Gentamicin Sulfate.
Payment limit per 80 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Gentamicin Sulfate.
Payment limit per 80 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Gentamicin Sulfate | Hikma Pharmaceuticals USA Inc. | 00143-9128-25 | 25 | $46.225 |
| Gentamicin Sulfate | Baxter Healthcare Corporation | 00338-0503-48 | 1 | $1.849 |
| Gentamicin Sulfate | Baxter Healthcare Corporation | 00338-0505-48 | 2 | $3.698 |
| Gentamicin Sulfate | Baxter Healthcare Corporation | 00338-0507-41 | 1 | $1.849 |
| Gentamicin Sulfate | Baxter Healthcare Corporation | 00338-0507-48 | 2 | $3.698 |
| Gentamicin Sulfate | Baxter Healthcare Corporation | 00338-0509-41 | 1 | $1.849 |
| Gentamicin Sulfate | Baxter Healthcare Corporation | 00338-0511-41 | 2 | $3.698 |
| Gentamicin Sulfate | Henry Schein Inc. | 00404-9865-02 | 1 | $1.849 |
| Gentamicin Sulfate | Henry Schein Inc. | 00404-9866-20 | 10 | $18.49 |
| Gentamicin Sulfate | Pfizer Inc | 00409-1207-03 | 25 | $46.225 |
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Gentamicin Sulfate | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1508-03 | 250 | $462.25 |
| Gentamicin Sulfate | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1597-03 | 25 | $46.225 |
| Gentamicin Sulfate | Eugia US LLC | 55150-0401-25 | 25 | $46.225 |
| Gentamicin Sulfate | Eugia US LLC | 55150-0402-25 | 25 | $46.225 |
| Gentamicin Sulfate | Eugia US LLC | 55150-0403-25 | 250 | $462.25 |
| Gentamicin Sulfate | FreseniUS Kabi USA, LLC | 63323-0010-02 | 25 | $46.225 |
| Gentamicin Sulfate | FreseniUS Kabi USA, LLC | 63323-0010-20 | 250 | $462.25 |
| Gentamicin Sulfate | FreseniUS Kabi USA, LLC | 63323-0010-94 | 25 | $46.225 |
| Gentamicin Sulfate | FreseniUS Kabi USA, LLC | 63323-0010-95 | 250 | $462.25 |
| Gentamicin Sulfate | FreseniUS Kabi USA, LLC | 63323-0173-02 | 25 | $46.225 |
| Gentamicin Sulfate | FreseniUS Kabi USA, LLC | 63323-0173-94 | 25 | $46.225 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $1.849 | −$0.076 | 80 MG | Garamycin gentamicin inj | v1, posted September 17, 2026 |
| 3Q26 | $1.925 | −$0.003 | 80 MG | Garamycin gentamicin inj | v1, posted September 15, 2026 |
| 2Q26 | $1.928 | −$0.238 | 80 MG | Garamycin gentamicin inj | v1, posted September 15, 2026 |
| 1Q26 | $2.166 | −$0.042 | 80 MG | Garamycin gentamicin inj | v1, posted September 15, 2026 |
| 4Q25 | $2.208 | −$0.407 | 80 MG | Garamycin gentamicin inj | v1, posted September 8, 2026 |
| 3Q25 | $2.615 | +$0.148 | 80 MG | Garamycin gentamicin inj | v1, posted March 10, 2026 |
| 2Q25 | $2.467 | −$0.003 | 80 MG | Garamycin gentamicin inj | v1, posted March 10, 2026 |
| 1Q25 | $2.47 | −$0.27 | 80 MG | Garamycin gentamicin inj | v1, posted December 19, 2025 |
| 4Q24 | $2.74 | +$0.674 | 80 MG | Garamycin gentamicin inj | v1, posted June 11, 2025 |
| 3Q24 | $2.066 | −$0.667 | 80 MG | Garamycin gentamicin inj | v1, posted June 11, 2025 |
| 2Q24 | $2.733 | +$0.048 | 80 MG | Garamycin gentamicin inj | v1, posted March 11, 2025 |
| 1Q24 | $2.685 | −$0.237 | 80 MG | Garamycin gentamicin inj | v1, posted December 19, 2024 |
| 4Q23 | $2.922 | −$0.07 | 80 MG | Garamycin gentamicin inj | v1, posted October 10, 2024 |
| 3Q23 | $2.992 | +$0.455 | 80 MG | Garamycin gentamicin inj | v1, posted June 5, 2024 |
| 2Q23 | $2.537 | −$0.257 | 80 MG | Garamycin gentamicin inj | v1, posted February 23, 2024 |
| 1Q23 | $2.794 | +$0.132 | 80 MG | Garamycin gentamicin inj | v1, posted December 6, 2023 |
| 4Q22 | $2.662 | +$0.297 | 80 MG | Garamycin gentamicin inj | v1, posted June 22, 2023 |
| 3Q22 | $2.365 | +$0.802 | 80 MG | Garamycin gentamicin inj | v1, posted June 9, 2023 |
| 2Q22 | $1.563 | +$0.15 | 80 MG | Garamycin gentamicin inj | v1, posted December 14, 2022 |
| 1Q22 | $1.413 | −$0.262 | 80 MG | Garamycin gentamicin inj | v1, posted June 8, 2022 |
| 4Q21 | $1.675 | −$0.211 | 80 MG | Garamycin gentamicin inj | v1, posted June 2, 2022 |
| 3Q21 | $1.886 | −$0.06 | 80 MG | Garamycin gentamicin inj | v1, posted June 2, 2022 |
| 2Q21 | $1.946 | +$0.168 | 80 MG | Garamycin gentamicin inj | v1, posted March 1, 2022 |
| 1Q21 | $1.778 | – | 80 MG | Garamycin gentamicin inj | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.